TTK HEALTHCARE LTD.-$

TTK Healthcare Ltd. has announced its 68th Annual General Meeting (AGM) scheduled for Friday, July 24, 2026, at 12:00 noon. The meeting will be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM) in compliance with MCA circulars and relevant laws. The company has also submitted the soft copy of its Annual Report for the Financial Year 2025-26 and the Notice of the 68th AGM, as per Regulation 34(1) of SEBI (LODR) Regulations, 2015. Both documents have been sent to shareholders electronically and are available on the company's website. The report includes financial highlights, board of directors' details, company secretary, registered office, factories, bankers, auditors, and registrar details.

TTK Healthcare Ltd has announced its 68th Annual General Meeting (AGM) will be held on Friday, July 24, 2026, at 12:00 noon via Video Conferencing/Other Audio Visual Means (VC/OAVM). The company has filed its Annual Report for the Financial Year 2025-26, in compliance with SEBI (LODR) Regulations, 2015. The report and the notice of the AGM have been sent to shareholders electronically and are also available on the company's website. The filing includes details of the Board of Directors, Company Secretary, registered office, factories, depots, bankers, and auditors. Financial highlights for FY2025-26 are presented alongside previous years, showing revenue from continuing operations.

TTK Healthcare Ltd has released its Annual Report for the Financial Year 2025-26, along with the notice for its 68th Annual General Meeting (AGM). The AGM is scheduled for July 24, 2026, at 12:00 noon, to be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM). The report, submitted as per SEBI (LODR) Regulations, 2015, includes financial highlights, board's report, corporate governance, and sustainability reports. The company has also uploaded the Annual Report and AGM notice on its website and sent them to shareholders electronically. The financial highlights indicate Revenue from Operations and Other Income for FY 2025-26 was ₹87,274.83 lakhs.

TTK Healthcare Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, adhering to SEBI regulations. The report details the company's commitment to sustainable growth, aligning its operations with customer needs while minimizing environmental and social impacts. It covers general disclosures including corporate identity, registered office, financial year, stock exchange listings, paid-up capital, and contact details for BRSR queries. The company's business activities encompass the manufacture and distribution of Consumer, Animal Welfare, and Food Products, along with Medical and Protective Devices. The report also outlines operational details, market reach across 28 states and 8 union territories in India, and international presence in 28 countries, with exports contributing 6.41% to turnover. Customer base includes direct consumers, distributors, healthcare professionals, and institutional clients.

TTK Healthcare Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from July 01, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the First Quarter ending June 30, 2026. All relevant parties have been informed not to trade in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.

TTK Healthcare Ltd has announced that the Record Date for its 68th Annual General Meeting (AGM) and for the declaration of Dividend has been set for Friday, July 17, 2026. The AGM itself is scheduled to be held on Friday, July 24, 2026, at 12:00 noon, via Video Conferencing (VC) and Other Audio-Visual Means (OAVM), in compliance with relevant circulars from the Ministry of Corporate Affairs and SEBI. This record date will determine the voting rights of shareholders and beneficial owners.

TTK Healthcare Ltd. has paid a penalty of ₹9,93,320 to the Customs Department following a disagreement over the classification of imported products. The Customs Department reclassified the products from 'Mechano-therapy Appliances' (7.5% duty) to 'Massage Apparatus' (10% duty). TTK Healthcare paid the differential duty of 2.5% along with interest. While the Customs Department insisted on a penalty of 15% of the differential duty, the company voluntarily paid the penalty to resolve the matter.

TTK Healthcare Ltd. announced the audited financial results for the fourth quarter and year ended March 31, 2026. The Board of Directors recommended a dividend of ₹10 per equity share (100%) subject to shareholder approval. The board approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of 5 years and the appointment of M/s Geeyes & Co. as the Cost Auditor for FY 2026-27. The 68th Annual General Meeting is scheduled for July 24, 2026, via video conferencing.

TTK Healthcare Ltd's board approved the audited financial results for the fourth quarter and year ended March 31, 2026. A dividend of ₹10 per equity share (100%) has been recommended, subject to shareholder approval. The board also approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of 5 years and the appointment of M/s Geeyes & Co. as the Cost Auditor for FY 2026-27. The 68th Annual General Meeting is scheduled for July 24, 2026, via video conferencing.

TTK Healthcare Ltd. announced the audited financial results for the fourth quarter and year ended March 31, 2026. The Board of Directors recommended a dividend of ₹10 per equity share (100%) for FY26, subject to shareholder approval. The reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of 5 years was approved. M/s Geeyes & Co. were appointed as Cost Auditor for FY27. The 68th Annual General Meeting is scheduled for July 24, 2026, via video conferencing.